Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Jacinda C. Abdul-Mutakabbir, PharmD, MPH (she/her/hers)

Assistant Professor of Clinical Pharmacy
University of California San Diego
San Diego, CA, United States

Dr. Jacinda Abdul-Mutakabbir is an Assistant Professor of Clinical Pharmacy at the University of California San Diego in the Skaggs School of Pharmacy and Pharmaceutical Sciences and the Division of the Black Diaspora and African American Studies. Her research is based on antimicrobial resistance and stewardship, where she identifies health disparities in various infectious diseases and further explores the utility of preventative therapeutics in narrowing health equity gaps. She has published more than 50 articles focused on identifying racial and social vulnerability differences in various infectious disease states, including Clostridium difficile infection, candidemia, and others. Her dedication to improving public health has been recognized by the United States Public Health Services, as she was the 2017 recipient of the USPHS Outstanding Service Award, and she currently serves as an appointed member of the CVSH Health Equity National Advisory Board. She was also the 2021 recipient of the Society of Infectious Disease Gita Patel Best Practice Award, the awardee of the 2022 American Pharmacists Association-Immunization Champion (Honorable Mention) award, and the 2021 recipient of the Wayne State University Warrior of Distinction of Alumni Award. Most recently, Dr. Abdul-Mutakabbir was named the 2023 recipient of the Infectious Diseases Society of America (IDSA) Clinical Practice Innovation Award. Dr. Abdul-Mutakabbir remains an active member of several professional organizations, including the American Society of Microbiology (ASM), IDSA, and the Society for Healthcare Epidemiology of America (SHEA).

Disclosure(s): CSL Sequiris: Advisor/Consultant, Honoraria; GSK: Advisor/Consultant, Honoraria; Shionogi: Advisor/Consultant, Honoraria

Presentation(s):